馬德里加爾製藥公司
US ˙ NasdaqGS ˙ US5588681057

簡介

本頁面提供了有關 Keith R Gollust 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Keith R Gollust已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:MDGL / Madrigal Pharmaceuticals, Inc. Director 12,489
如何解讀這些圖表

以下圖表顯示了在Keith R Gollust進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

MDGL / Madrigal Pharmaceuticals, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 MDGL / Madrigal Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2015-04-06 SNTA Gollust Keith R 350,000 1.7500 350,000 1.7500 612,500 731
2013-11-13 SNTA Gollust Keith R 150,000 3.7500 150,000 3.7500 562,500
2012-06-29 SNTA Gollust Keith R 150,000 5.3460 150,000 5.3460 801,900

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

MDGL / Madrigal Pharmaceuticals, Inc. Insider Trades
MDGL / Madrigal Pharmaceuticals, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 MDGL / Madrigal Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2015-12-14 SNTA Gollust Keith R 300,000 0.3223 300,000 0.3223 96,690 218
2015-12-11 SNTA Gollust Keith R 300,000 0.3701 300,000 0.3701 111,030
2015-12-09 SNTA Gollust Keith R 145,892 0.3786 145,892 0.3786 55,235
2015-12-08 SNTA Gollust Keith R 300,000 0.3802 300,000 0.3802 114,060
2015-12-07 SNTA Gollust Keith R 300,000 0.3861 300,000 0.3861 115,830
2015-11-17 SNTA Gollust Keith R 100,000 0.4140 100,000 0.4140 41,400
2015-11-10 SNTA Gollust Keith R 188,322 0.5472 188,322 0.5472 103,050

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

MDGL / Madrigal Pharmaceuticals, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Keith R Gollust 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2021-06-21 2021-06-17 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 12,489 12,489
2020-06-18 2020-06-17 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 6,000 6,000
2019-07-01 2019-06-27 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 10,000 10,000
2018-06-21 2018-06-19 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 10,000 10,000
2017-06-30 2017-06-29 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 10,000 10,000
2016-11-04 2016-07-22 4/A MDGL MADRIGAL PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 20,000 20,000
2016-10-24 2016-07-22 4 MDGL MADRIGAL PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 20,000 20,000
2015-12-15 2015-12-14 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
S - Sale -300,000 1,539,169 -16.31 0.32 -96,690 496,074
2015-12-15 2015-12-11 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
S - Sale -300,000 1,839,169 -14.02 0.37 -111,030 680,676
2015-12-09 2015-12-09 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
S - Sale -145,892 2,139,169 -6.38 0.38 -55,235 809,889
2015-12-09 2015-12-08 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
S - Sale -300,000 2,285,061 -11.61 0.38 -114,060 868,780
2015-12-09 2015-12-07 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
S - Sale -300,000 2,585,061 -10.40 0.39 -115,830 998,092
2015-11-19 2015-11-17 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
S - Sale -100,000 2,885,061 -3.35 0.41 -41,400 1,194,415
2015-11-13 2015-11-10 4/A SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
S - Sale -188,322 2,985,061 -5.93 0.55 -103,050 1,633,425
2015-11-12 2015-11-10 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
S - Sale 188,322 2,985,061 6.73 0.55 103,050 1,633,425
2015-07-06 2015-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
A - Award 15,000 15,000
2015-07-06 2015-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
A - Award 20,000 20,000
2015-07-06 2015-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 4,545 401,764 1.14
2015-07-06 2015-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 4,545 401,764 1.14
2015-07-06 2015-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 4,545 3,741,057 0.12
2015-07-06 2015-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 13,636 388,129 3.64
2015-07-06 2015-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 22,727 374,493 6.46
2015-04-08 2015-04-06 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
P - Purchase 350,000 3,173,383 12.40 1.75 612,500 5,553,420
2014-07-03 2014-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
A - Award 4,500 4,500
2014-07-03 2014-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
A - Award 10,000 10,000
2014-07-03 2014-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 1,219 351,766 0.35
2014-07-03 2014-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 1,219 351,766 0.35
2014-07-03 2014-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 2,439 349,328 0.70
2014-07-03 2014-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 4,878 346,889 1.43
2014-07-03 2014-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 9,756 342,011 2.94
2013-11-15 2013-11-13 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
P - Purchase 150,000 2,823,383 5.61 3.75 562,500 10,587,686
2013-07-03 2013-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
A - Award 4,500 4,500
2013-07-03 2013-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
A - Award 10,000 10,000
2013-07-03 2013-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 1,000 332,255 0.30
2013-07-03 2013-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 1,000 331,255 0.30
2013-07-03 2013-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 2,000 330,255 0.61
2013-07-03 2013-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 4,000 328,255 1.23
2013-07-03 2013-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 8,000 324,255 2.53
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
M - Exercise -2,250 2,250 -50.00
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
M - Exercise -5,000 5,000 -50.00
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
M - Exercise -2,500 0 -100.00
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
M - Exercise -2,500 0 -100.00
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
M - Exercise -5,500 0 -100.00
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
M - Exercise -5,500 0 -100.00
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
M - Exercise -2,500 0 -100.00
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
M - Exercise -5,500 0 -100.00
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
M - Exercise -2,500 0 -100.00
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
M - Exercise -5,500 0 -100.00
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
M - Exercise -75,000 0 -100.00
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
M - Exercise 2,250 316,255 0.72 5.47 12,308 1,729,915
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
M - Exercise 5,000 314,005 1.62 5.47 27,350 1,717,607
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
M - Exercise 2,500 309,005 0.82 5.09 12,725 1,572,835
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
M - Exercise 5,500 306,505 1.83 5.09 27,995 1,560,110
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
M - Exercise 2,500 301,005 0.84 2.59 6,475 779,603
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
M - Exercise 5,500 298,505 1.88 2.59 14,245 773,128
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
M - Exercise 2,500 293,005 0.86 2.38 5,950 697,352
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
M - Exercise 5,500 290,505 1.93 2.38 13,090 691,402
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
M - Exercise 2,500 285,005 0.88 7.03 17,575 2,003,585
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
M - Exercise 5,500 282,505 1.99 7.03 38,665 1,986,010
2013-01-24 2013-01-23 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
M - Exercise 75,000 277,005 37.13 10.84 813,225 3,003,565
2012-12-14 2012-12-12 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 175,000 175,000 8.60 1,505,000 1,505,000
2012-12-14 2012-12-12 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 75,000 2,673,383 2.89 8.60 645,000 22,991,094
2012-07-27 2012-07-25 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 770,416 2,598,383 42.15 6.49 5,000,000 16,863,506
2012-07-03 2012-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
A - Award 4,500 4,500
2012-07-03 2012-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Director Stock Option (Right to Buy)
A - Award 10,000 10,000
2012-07-03 2012-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 914 202,005 0.45
2012-07-03 2012-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 914 202,005 0.45
2012-07-03 2012-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 1,828 200,177 0.92
2012-07-03 2012-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 3,656 198,349 1.88
2012-07-03 2012-07-01 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
A - Award 7,312 194,693 3.90
2012-07-02 2012-06-29 4 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
P - Purchase 150,000 1,827,967 8.94 5.35 801,900 9,772,312
2007-02-05 3 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
34,357
2007-02-05 3 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
50,000
2007-02-05 3 SNTA SYNTA PHARMACEUTICALS CORP
Common Stock
915,516
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)